Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 251-275 of 380 matching filings.

Per page
25
Current page
11
4

4 filing

Filing date
14 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
08 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262262

FORM 424B3

Filing date
01 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262262

EFFECT filing

Filing date
31 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jan 2022
Reporting date
05 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-262262

FORM S-3

Filing date
20 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Dec 2021
Reporting date
06 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Nov 2021
Reporting date
16 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

FORM 10-Q FOR JUNE 30, 2021

Filing date
13 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
19 Jul 2021
Reporting date
19 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
15 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2021
Reporting date
15 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .